StockData
Oncolytics Biotech Inc logo

Oncolytics Biotech Inc (ONCY) stock

ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.35−0.04 (-10.37%)

Close on Nov 20, 2026Market cap $44.64MP/E –Yield –

Oncolytics Biotech free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for Oncolytics Biotech

Oncolytics Biotech has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Oncolytics Biotech figures

See a number that looks wrong?